nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.817	1	CbGbCtD
Topotecan—Lung neoplasm malignant—Riluzole—amyotrophic lateral sclerosis	0.02	0.112	CcSEcCtD
Topotecan—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00588	0.033	CcSEcCtD
Topotecan—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00567	0.0318	CcSEcCtD
Topotecan—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00567	0.0318	CcSEcCtD
Topotecan—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00524	0.0294	CcSEcCtD
Topotecan—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.00424	0.0238	CcSEcCtD
Topotecan—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00408	0.0229	CcSEcCtD
Topotecan—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0225	CcSEcCtD
Topotecan—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00363	0.0203	CcSEcCtD
Topotecan—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00348	0.0195	CcSEcCtD
Topotecan—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00341	0.0191	CcSEcCtD
Topotecan—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0169	CcSEcCtD
Topotecan—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0155	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00262	0.0147	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00257	0.0144	CcSEcCtD
Topotecan—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00239	0.0134	CcSEcCtD
Topotecan—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0132	CcSEcCtD
Topotecan—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00229	0.0128	CcSEcCtD
Topotecan—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00226	0.0127	CcSEcCtD
Topotecan—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0126	CcSEcCtD
Topotecan—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0126	CcSEcCtD
Topotecan—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0022	0.0123	CcSEcCtD
Topotecan—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0123	CcSEcCtD
Topotecan—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0121	CcSEcCtD
Topotecan—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0119	CcSEcCtD
Topotecan—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0119	CcSEcCtD
Topotecan—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0114	CcSEcCtD
Topotecan—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0113	CcSEcCtD
Topotecan—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00201	0.0113	CcSEcCtD
Topotecan—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.002	0.0112	CcSEcCtD
Topotecan—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.002	0.0112	CcSEcCtD
Topotecan—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00183	0.0102	CcSEcCtD
Topotecan—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0102	CcSEcCtD
Topotecan—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00182	0.0102	CcSEcCtD
Topotecan—Chills—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0101	CcSEcCtD
Topotecan—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00998	CcSEcCtD
Topotecan—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00983	CcSEcCtD
Topotecan—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00951	CcSEcCtD
Topotecan—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00945	CcSEcCtD
Topotecan—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00912	CcSEcCtD
Topotecan—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00909	CcSEcCtD
Topotecan—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00898	CcSEcCtD
Topotecan—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00887	CcSEcCtD
Topotecan—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0088	CcSEcCtD
Topotecan—Cough—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00858	CcSEcCtD
Topotecan—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00837	CcSEcCtD
Topotecan—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00837	CcSEcCtD
Topotecan—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00837	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00831	CcSEcCtD
Topotecan—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00827	CcSEcCtD
Topotecan—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00802	CcSEcCtD
Topotecan—Infection—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00797	CcSEcCtD
Topotecan—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00787	CcSEcCtD
Topotecan—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00786	CcSEcCtD
Topotecan—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00779	CcSEcCtD
Topotecan—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00776	CcSEcCtD
Topotecan—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00765	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00731	CcSEcCtD
Topotecan—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00721	CcSEcCtD
Topotecan—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00715	CcSEcCtD
Topotecan—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00706	CcSEcCtD
Topotecan—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00698	CcSEcCtD
Topotecan—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00693	CcSEcCtD
Topotecan—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00692	CcSEcCtD
Topotecan—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00686	CcSEcCtD
Topotecan—Pain—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00686	CcSEcCtD
Topotecan—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00661	CcSEcCtD
Topotecan—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00656	CcSEcCtD
Topotecan—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00638	CcSEcCtD
Topotecan—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00634	CcSEcCtD
Topotecan—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00634	CcSEcCtD
Topotecan—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00591	CcSEcCtD
Topotecan—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00576	CcSEcCtD
Topotecan—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00568	CcSEcCtD
Topotecan—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000979	0.00549	CcSEcCtD
Topotecan—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000946	0.00531	CcSEcCtD
Topotecan—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00091	0.0051	CcSEcCtD
Topotecan—Rash—Riluzole—amyotrophic lateral sclerosis	0.000902	0.00506	CcSEcCtD
Topotecan—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000902	0.00506	CcSEcCtD
Topotecan—Headache—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00503	CcSEcCtD
Topotecan—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00085	0.00477	CcSEcCtD
Topotecan—TOP1MT—nervous system—amyotrophic lateral sclerosis	0.000645	0.13	CbGeAlD
Topotecan—TOP1MT—central nervous system—amyotrophic lateral sclerosis	0.000621	0.125	CbGeAlD
Topotecan—TOP1MT—cerebellum—amyotrophic lateral sclerosis	0.000607	0.122	CbGeAlD
Topotecan—TOP1MT—brain—amyotrophic lateral sclerosis	0.000493	0.0992	CbGeAlD
Topotecan—TOP1—medulla oblongata—amyotrophic lateral sclerosis	0.000453	0.0911	CbGeAlD
Topotecan—TOP1—spinal cord—amyotrophic lateral sclerosis	0.000404	0.0812	CbGeAlD
Topotecan—TOP1—cerebellum—amyotrophic lateral sclerosis	0.00032	0.0644	CbGeAlD
Topotecan—TOP1—brain—amyotrophic lateral sclerosis	0.00026	0.0523	CbGeAlD
Topotecan—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000161	0.0323	CbGeAlD
Topotecan—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000143	0.0288	CbGeAlD
Topotecan—ABCB1—embryo—amyotrophic lateral sclerosis	0.000124	0.0249	CbGeAlD
Topotecan—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000114	0.0229	CbGeAlD
Topotecan—ABCG2—brain—amyotrophic lateral sclerosis	9.23e-05	0.0186	CbGeAlD
Topotecan—CYP3A4—nervous system—amyotrophic lateral sclerosis	8.41e-05	0.0169	CbGeAlD
Topotecan—CYP3A4—central nervous system—amyotrophic lateral sclerosis	8.1e-05	0.0163	CbGeAlD
Topotecan—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	7.93e-05	0.0159	CbGeAlD
Topotecan—ABCB1—spinal cord—amyotrophic lateral sclerosis	7.07e-05	0.0142	CbGeAlD
Topotecan—ABCB1—nervous system—amyotrophic lateral sclerosis	5.96e-05	0.012	CbGeAlD
Topotecan—ABCB1—central nervous system—amyotrophic lateral sclerosis	5.73e-05	0.0115	CbGeAlD
Topotecan—ABCB1—cerebellum—amyotrophic lateral sclerosis	5.61e-05	0.0113	CbGeAlD
Topotecan—ABCB1—brain—amyotrophic lateral sclerosis	4.55e-05	0.00915	CbGeAlD
